FOX BIZ NEWS: AstraZeneca expects COVID-19 phase 3 trial results 'later this year' after pause


AstraZeneca expects COVID-19 phase 3 trial results 'later this year' after pause



AstraZeneca announced Wednesday that it still expects results from phase three of its COVID-19 vaccine trial to be ready by the end of 2020.

Comments

Popular posts from this blog

FOX BIZ NEWS: Phantom Space startup announces world's first 100% US-based satellite supply chain after acquiring StratSpace